Efficacy and Safety of Panax Notoginseng Saponins (Xueshuantong) in Patients With Acute Ischemic Stroke (EXPECT) Trial: Rationale and Design

Efficacy and Safety of Panax Notoginseng Saponins (Xueshuantong) in Patients With Acute Ischemic Stroke (EXPECT) Trial: Rationale and Design

Background: Although revascularization treatment is recommended as the first-line therapy for patients with non-minor acute ischemic stroke (AIS), it only benefits a minority of patients. Previous studies have reported the positive effects of Panax notoginseng saponins (PNS) (Xueshuantong lyophilize...

Full description

Bibliographic Details
Main Authors: Luda Feng, Fang Han, Li Zhou, Shengxian Wu, Yawei Du, Dandan Zhang, Chi Zhang, Ying Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pharmacology
Subjects:
acute ischemic stroke
panax notoginseng saponins
xueshuantong
efficacy
safety
randomized controlled trial
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.648921/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.648921/full

Similar Items